Osteoclast-mediated resorption on additively manufactured porous metal and plasma-sprayed HA-coated Ti implants
Source abstract
Abstract
Load-bearing bone substitutes must be designed to stimulate bone formation and allow crosstalk between the two primary skeletal cells, bone-forming osteoblasts, and bone-resorbing osteoclasts. Compared to the dense implants, surface-modified, additively manufactured porous implants have shown osteogenic potential. Surface modification of metal implants by plasma-sprayed hydroxyapatite (HA) coating, show better clinical applicability due to their significant osteogenic potential, through better osteoblast proliferation and osseointegration. This study investigates additively manufactured porous metallic surface and plasma-sprayed HA-coated Ti on the proliferation and differentiation of monocytic cells into osteoclasts and their resorptive activity. Our results reveal that porous Ti6Al4V and porous Ta enhanced TRAP activity, compared to the control (p < 0.05). Similarly, plasma-sprayed HA-coated Ti implants also showed enhanced osteoclast-mediated resorption activity after 10 and 20 days of culture (p < 0.05). Osteoclast cell morphology was noted on both porous metal implants and HA-coated Ti, confirming their bone remodeling capability, essential for bone repair and regeneration.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. P.A. Hill, Bone remodeling. Br. J. Orthodontics 25(2), 101–107 (1998)10.1093/ortho/25.2.101 ↗
2. P. Proff, P. Römer, The molecular mechanism behind bone remodeling: a review. Clin. Oral Invest. 13(4), 355–362 (2009)10.1007/s00784-009-0268-2 ↗
3. T.J. Martin, E. Seeman, Bone remodeling: its local regulation and the emergence of bone fragility. Best Pract. Res. Clin. Endocrinol. Metab. 22(5), 701–722 (2008)10.1016/j.beem.2008.07.006 ↗
4. T. Sözen, L. Özışık, N.Ç. Başaran, An overview and management of osteoporosis. Eur. J. Rheumatol. 4(1), 46 (2017)10.5152/eurjrheum.2016.048 ↗
5. S.S. Mukka, G.N. Andersson, K.R. Hultenby, O.G. Sköldenberg, J.P. Nordahl, T.M. Eisler, Osteoclasts in periprosthetic osteolysis: the charnley arthroplasty revisited. J. Arthroplasty 32(10), 3219–3227 (2017)10.1016/j.arth.2017.05.030 ↗
6. H. Löfvall, H. Newbould, M.A. Karsdal, M.H. Dziegiel, J. Richter, K. Henriksen, C.S. Thudium, Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes. Arthritis Res. Ther. 20(1), 67 (2018)10.1186/s13075-018-1564-5 ↗
7. A. Maurizi, N. Rucci, The osteoclast in bone metastasis: player and target. Cancers 10(7), 218 (2018)10.3390/cancers10070218 ↗
8. S.B. Goodman, J. Gallo, Periprosthetic osteolysis: mechanisms, prevention and treatment. J. Clin. Med. 8(12), 2091 (2019)10.3390/jcm8122091 ↗
9. D.B. Logar, R. Komadina, J. Preželj, B. Ostanek, Z. Trošt, J. Marc, Expression of bone resorption genes in osteoarthritis and in osteoporosis. J. Bone Miner. Metab. 25(4), 219–225 (2007)10.1007/s00774-007-0753-0 ↗
10. K. Ogawa, M. Mawatari, M. Komine, M. Shigematsu, M. Kitajima, A. Kukita, T. Hotokebuchi, Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis. J. Bone Miner. Metab. 25(6), 354–360 (2007)10.1007/s00774-007-0761-0 ↗
11. S. Bose, D. Ke, H. Sahasrabudhe, A. Bandyopadhyay, Additive manufacturing of biomaterials. Prog. Mater Sci. 93, 45–111 (2018)10.1016/j.pmatsci.2017.08.003 ↗
12. S. Bose, M. Roy, A. Bandyopadhyay, Recent advances in bone tissue engineering scaffolds. Trends Biotechnol. 30(10), 546–554 (2012)10.1016/j.tibtech.2012.07.005 ↗
13. B.V. Krishna, W. Xue, S. Bose, A. Bandyopadhyay, Engineered porous metals for implants. Jom 60(5), 45–48 (2008)10.1007/s11837-008-0059-2 ↗
14. J. Black, Biologic performance of tantalum. Clin. Mater. 16(3), 167–173 (1994)10.1016/0267-6605(94)90113-9 ↗
15. S. Vahabzadeh, M. Roy, A. Bandyopadhyay, S. Bose, Phase stability and biological property evaluation of Plasma sprayed hydroxyapatite coatings for orthopedic and dental applications. Acta Biomater. 17, 47–55 (2015)10.1016/j.actbio.2015.01.022 ↗
16. Y. Liu, B. Rath, M. Tingart, J. Eschweiler, Role of implants surface modification in osseointegration: A systematic review. J. Biomed. Mater. Res. Part A 108(3), 470–484 (2020)10.1002/jbm.a.36829 ↗
17. X. Liu, P.K. Chu, C. Ding, Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mater. Sci. Eng. R 47(3–4), 49–121 (2004)10.1016/j.mser.2004.11.001 ↗
18. M. Marchisio, M. Di Carmine, R. Pagone, A. Piattelli, S. Miscia, Implant surface roughness influences osteoclast proliferation and differentiation. J. Biomed. Mater. Res. Part B 75(2), 251–256 (2005)10.1002/jbm.b.30287 ↗
19. T. Hefti, M. Frischherz, N.D. Spencer, H. Hall, F. Schlottig, A comparison of osteoclast resorption pits on bone with titanium and zirconia surfaces. Biomaterials 31(28), 7321–7331 (2010)10.1016/j.biomaterials.2010.06.009 ↗
20. T. Alliston, R. Derynck, Interfering with bone remodeling. Nature 416(6882), 686–687 (2002)10.1038/416686a ↗
21. P. Frayssinet, N. Rouquet, F. Tourenne, J. Fages, D. Hardy, G. Bonel, Cell-degradation of calcium phosphate ceramics. Cells Mater. 3(4), 383–394 (1993)
22. G.D. Roodman, Advances in bone biology: the osteoclast. Endocr. Rev. 17(4), 308–332 (1996)
23. C. Steffi, Z. Shi, C.H. Kong, W. Wang, Modulation of osteoclast interactions with orthopaedic biomaterials. J. Funct. Biomater. 9(1), 18 (2018)10.3390/jfb9010018 ↗
24. S. Makihira, Y. Mine, E. Kosaka, H. Nikawa, Titanium surface roughness accelerates RANKL-dependent differentiation in the osteoclast precursor cell line, RAW264. 7. Dent. Mater. J. 26(5), 739–745 (2007)10.4012/dmj.26.739 ↗
25. Sims, N. A., & Martin, T. J. (2014). Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. BoneKEy reports, 3.10.1038/bonekey.2013.215 ↗
26. K. Das, S. Bose, A. Bandyopadhyay, Surface modifications and cell–materials interactions with anodized Ti. Acta Biomater. 3(4), 573–585 (2007)10.1016/j.actbio.2006.12.003 ↗
27. J. Lincks, B.D. Boyan, C.R. Blanchard, C.H. Lohmann, Y. Liu, D.L. Cochran, D.D. Dean, Z. Schwartz, Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 19(23), 2219–2232 (1998)10.1016/S0142-9612(98)00144-6 ↗
28. J.D. Bobyn, G.J. Stackpool, S.A. Hacking, M. Tanzer, J.J. Krygier, Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. J. Bone Jt. Surg. Br. 81(5), 907–914 (1999)10.1302/0301-620X.81B5.0810907 ↗
29. W. Xue, B.V. Krishna, A. Bandyopadhyay, S. Bose, Processing and biocompatibility evaluation of laser processed porous titanium. Acta Biomater. 3(6), 1007–1018 (2007)10.1016/j.actbio.2007.05.009 ↗
30. S. Bose, S.F. Robertson, A. Bandyopadhyay, Surface modification of biomaterials and biomedical devices using additive manufacturing. Acta Biomater. 66, 6–22 (2018)10.1016/j.actbio.2017.11.003 ↗
31. M. Roy, A. Bandyopadhyay, S. Bose, Induction plasma sprayed nano hydroxyapatite coatings on titanium for orthopaedic and dental implants. Surf. Coat. Technol. 205(8–9), 2785–2792 (2011)10.1016/j.surfcoat.2010.10.042 ↗
32. D. Arcos, M. Vallet-Regí, Substituted hydroxyapatite coatings of bone implants. J. Mater. Chem. B 8(9), 1781–1800 (2020)10.1039/C9TB02710F ↗
33. S. Vahabzadeh, M. Roy, S. Bose, Effects of silicon on osteoclast cell mediated degradation, in vivo osteogenesis and vasculogenesis of brushite cement. J. Mater. Chem. B 3(46), 8973–8982 (2015)10.1039/C5TB01081K ↗